AbbVie Inc. (ABBV) Financial Statements

Executive TeamFinancials
Shareholders

AbbVie financial statements at a glance

AbbVie reported revenue of $56.33 billion for fiscal year 2024 (ended December 31, 2024), up 3.7% from fiscal year 2023. Net income was $4.24 billion, a net margin of 7.5%, and diluted earnings per share were $2.39.

At the end of fiscal year 2024 it had total assets of $135.16 billion, total liabilities of $131.80 billion and shareholders' equity of $3.33 billion, with cash and short-term investments of $5.56 billion and total debt of $67.14 billion.

Its operations brought in $18.81 billion of cash; capital spending was $974.00 million, leaving free cash flow of $17.83 billion.

The tables below show the income statement, balance sheet and cash flow statement; the key figures of the last 5 fiscal years are at the bottom of the page.

Figures from company filings, in USD; latest fiscal year ended December 31, 2024.

ABBV logo

AbbVie Inc.

ABBVUnited States
Healthcare
USD (Local)

Income Statement

Annual • USD

Basic EPS
2.391
Prev Year: 2.42
YoY: -1.2%
Total Revenue
-
Prev Year: 56.33B
Diluted EPS
2.36
Prev Year: 2.39
YoY: -1.3%
Cost of Revenue
-
Prev Year: 16.90B
Weighted Average Shares (basic)
1.77B
Prev Year: 1.77B
YoY: +0.1%
Gross Profit
-
Prev Year: 39.43B
Weighted Average Shares (diluted)
1.77B
Prev Year: 1.77B
YoY: 0.0%
Operating Expense
-
Prev Year: 27.54B
Values in USD

AbbVie key figures by fiscal year

FY2025FY2024FY2023FY2022FY2021
Revenue–$56.3B$54.3B$58.1B$56.2B
Gross profit–$39.4B$33.9B$40.6B$38.8B
Operating income–$11.9B$12.8B$18.1B$17.9B
Net income–$4.2B$4.8B$11.8B$11.5B
Diluted EPS$2.36$2.39$2.72$6.63$6.45
Total assets–$135.2B$134.7B$138.8B$146.5B
Total liabilities–$131.8B$124.3B$121.5B$131.1B
Shareholders' equity–$3.3B$10.4B$17.3B$15.4B
Cash and short-term investments–$5.6B$12.8B$9.2B$9.8B
Total debt–$67.1B$59.4B$63.3B$76.7B
Operating cash flow–$18.8B$22.8B$24.9B$22.8B
Capital spending–$974.0M$777.0M$695.0M$787.0M
Free cash flow–$17.8B$22.1B$24.2B$22.0B

In USD. Fiscal years as reported by the company; statements on this page go back to fiscal year 2014.

Questions and answers

What was AbbVie's revenue in fiscal year 2024?

$56.33 billion, up 3.7% from $54.32 billion in fiscal year 2023.

How much profit does AbbVie make?

AbbVie reported net income of $4.24 billion for fiscal year 2024 (7.5% of revenue); operating income was $11.89 billion.

How much cash and debt does AbbVie have?

At the end of fiscal year 2024: cash and short-term investments of $5.56 billion and total debt of $67.14 billion.

What is AbbVie's free cash flow?

$17.83 billion in fiscal year 2024 (operating cash flow of $18.81 billion minus capital spending of $974.00 million).

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube